Our results showed that MEDAG was highly expressed in breast cancer and that breast cancer patients with high MEDAG showed aggressive vascular invasion, lymph node metastasis, and poor disease-free survival. The gene discussed is MEDAG; the disease is metastatic malignant neoplasm in the lymph nodes.